Helen Kim

Helen Kim is an accomplished professional in regulatory affairs with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Regulatory Affairs at Umoja Biopharma, Helen has previously held senior leadership roles at Dendreon Corporation and Juno Therapeutics, Inc., including positions such as Senior Director and Director of Regulatory Affairs. Additionally, Helen has provided regulatory consultancy services and has a strong educational background, having studied at the University of California, Davis.